- Home
- CDTX vs HURN Comparison
CDTX vs HURN Comparison
Compare CDTX & HURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- HURN
- Stock Information
- Founded
- CDTX 2012
- HURN 2002
- Country
- CDTX United States
- HURN United States
- Employees
- CDTX N/A
- HURN N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- HURN Professional Services
- Sector
- CDTX Health Care
- HURN Consumer Discretionary
- Exchange
- CDTX Nasdaq
- HURN Nasdaq
- Market Cap
- CDTX 2.8B
- HURN 2.6B
- IPO Year
- CDTX 2015
- HURN 2004
- Fundamental
- Price
- CDTX $109.03
- HURN $165.40
- Analyst Decision
- CDTX Strong Buy
- HURN Strong Buy
- Analyst Count
- CDTX 13
- HURN 4
- Target Price
- CDTX $118.50
- HURN $175.25
- AVG Volume (30 Days)
- CDTX 986.8K
- HURN 176.6K
- Earning Date
- CDTX 11-06-2025
- HURN 10-28-2025
- Dividend Yield
- CDTX N/A
- HURN N/A
- EPS Growth
- CDTX N/A
- HURN 32.35
- EPS
- CDTX N/A
- HURN 5.98
- Revenue
- CDTX N/A
- HURN $1,618,977,000.00
- Revenue This Year
- CDTX N/A
- HURN $13.32
- Revenue Next Year
- CDTX N/A
- HURN $8.31
- P/E Ratio
- CDTX N/A
- HURN $28.36
- Revenue Growth
- CDTX N/A
- HURN 14.53
- 52 Week Low
- CDTX $12.54
- HURN $103.24
- 52 Week High
- CDTX $121.21
- HURN $174.26
- Technical
- Relative Strength Index (RSI)
- CDTX 57.26
- HURN 77.33
- Support Level
- CDTX $93.60
- HURN $150.49
- Resistance Level
- CDTX $107.00
- HURN $174.26
- Average True Range (ATR)
- CDTX 5.83
- HURN 4.24
- MACD
- CDTX -1.38
- HURN 1.48
- Stochastic Oscillator
- CDTX 39.96
- HURN 81.74
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About HURN Huron Consulting Group Inc.
Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.